Log in
Enquire now
‌

US Patent 12059449 Ophthalmic composition for treatment of dry eye disease

Patent 12059449 was granted and assigned to Novaliq on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease and provides for treatment methods thereof. The invention further provides kits comprising such compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12059449 Ophthalmic composition for treatment of dry eye disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.